Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
- [o.100] Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis (0)
- [o.101] Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy (0)
- [o.102] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant (0)
- [o.103] Omalizumab – an effective and safe treatment of therapyresistant chronic spontaneous urticaria (2)
- [o.104] Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria (3)
- [o.105] Effects of Antihistamines on Innate Immune Responses to Severe Bacterial Infection in Mice (0)
- [o.106] Adaptation and initial results of the polish version of the GA²LEN chronic urticaria quality of life questionnaire (0)
- [o.107] IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria? (0)
- [o.108] A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis (0)
- [o.109] IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune-suppression (0)
- [o.110] Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function (0)
- [o.111] Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA²LEN taskforce position paper (0)
- [o.112] Classification and diagnosis of urticaria: German language version of the international S3-guideline (2)
- [o.113] Therapy of urticaria: German language version of the international S3-guideline. (0)
- [o.114] Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase (4)
- [o.114a] Effect of omalizumab on thyroid function and autoantibody levels in patients with chronic spontaneous urticaria. Comment on: Monitoring of thyroid function in patients who exhibit IgE against thyreoperoxidase on Omalizumab (0)
- [o.115] High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria (0)
- [o.116] H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients’ Perspective of Effectiveness and Side Effects – A Retrospective Survey Study (2)
- [o.117] A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine– refractory chronic idiopathic urticaria (0)
- [o.118] T cell killing by tolerogenic dendritic cells protects from allergy in mice (0)
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.